Metachromatic Leukodystrophy clinical trials at UCSF

1 research study open to eligible people

Metachromatic leukodystrophy is a disease that damages myelin in the brain. UCSF is actively collecting data and samples from patients globally to study this disorder. This effort helps scientists investigate the disorder's effects on myelin and its progression.

Showing trials for

  • Myelin Disorders Biorepository Project

    open to all eligible people

    The Myelin Disorders Biorepository Project (MDBP) seeks to collect and analyze clinical data and biological samples from leukodystrophy patients worldwide to support ongoing and future research projects. The MDBP is one of the world's largest…

    San Francisco, California and other locations

Last updated: